Brentwood Donates 5,000 Face Shields to Penn State Health St. Joseph
Brentwood is proud to partner with Penn State Health St. Joseph in Berks County’s fight against COVID-19. The company donated 5,000 reusable face shields to the hospital to protect healthcare workers as the pandemic continues.
Brentwood President, Peter Rye, and his wife, Leigh, presented the donation to hospital representatives on Wednesday.
“We wanted to protect those working to keep us safe and healthy, particularly in the community where we live and operate,” said Rye. “We learned that [Penn State Health] St. Joe’s needed personal protection equipment, and we were happy to jump in and help.”
The company said its commitment to help during the pandemic will extend beyond Penn State Health St. Joseph, with more face shield donations throughout Berks County. Brentwood is also building partnerships with hospitals and businesses in the other domestic locations where the company operates – Lebanon, PA; Martinsburg, WV; and Hope, AR – with the intent of donating thousands more face shields.
When COVID-19 took hold in the U.S. two months ago, Brentwood assessed its capabilities and decided to develop the reusable face shield product. The company had never designed or manufactured personal protection equipment, but this was a challenge they were excited to take on.
“Our facilities were already equipped to form medical packaging and injection molded components,” said Walter Banta, Brentwood’s Senior Director of Operations, “so developing a face shield was an easy decision.”
The face shield design and tooling were completed within weeks, enabling Brentwood to ramp up production in its Reading, PA, facilities. These include an ISO Class 7 cleanroom and a state-of-the-art injection molding facility.
Several weeks ago, the company received official authorization from the U.S. Food & Drug Administration to supply its face shields specifically to healthcare workers fighting COVID-19. This approval falls within the Emergency Use Authorization (EUA) guidelines.
Brentwood’s face shields also protect non-healthcare essential workers, tasked with keeping grocery stores, warehouses, and other critical processes operational during this difficult time.
-
Most popular related searches
Related news
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol “DXR” after the transfer. The Company’s common stock will continue to trade on the NYSE American until the...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress with BVA-100® next generation development. The presentation will be available on-demand beginning at 7:00 a.m. ET...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake Forest School of Medicine and OHSU have been enrolling subjects since the onset of the pandemic. Dr. Jan Bakker, MD,...
-
Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced that the United States Patent and Trademark Office has issued the company a new patent (U.S. Patent No. 11,204,356 B2) that protects a proprietary clinical guidance system for volume management utilizing unique volume metrics combined with treatment pathways. “We are very excited to receive this patent, which covers key innovations in the use of blood volume analysis to optimally guide fluid...
Customer comments
No comments were found for Brentwood Donates 5,000 Face Shields to Penn State Health St. Joseph. Be the first to comment!